Navigation Links
Debate Focuses on Door-to-balloon Time in Heart Attack Treatment

In the treatment of heart attack, the 90-minute goal for inflation of an angioplasty balloon in a blocked coronary artery to restore normal blood flow is so revered its been codified in clinical guidelines, accreditation standards, and pay-for-performance programs. But is the 90-minute deadline really critical" Two experts will debate that question at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI).

Allowing no more than 90 minutes to elapse between patient arrival in the emergency room and inflation of the angioplasty balloonthe so-called door-to-balloon timeis clearly beneficial, said Eric R. Bates, M.D., a professor of internal medicine at the University of Michigan in Ann Arbor.

Many studies have shown that the size of a heart attack and the risk of death are directly related to the amount of time the heart is ischemic, or starved for blood and oxygen. Opening the blocked artery within 90 minutes has repeatedly been associated with better outcomes.

"For years weve known that time is muscle," Dr. Bates said. "The sooner you unblock the coronary artery, the more heart muscle you can salvage."

Timothy D. Henry, M.D., FSCAI, has no quarrel with keeping a close eye on the clock when treating heart attack patients, but said a hard-and-fast deadline may be counterproductive in some cases. "Time is important, and we need to treat patients as quickly as we can," said Dr. Henry, the director of research and an interventional cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis. "But there is clear evidence that 90 minutes is arbitrary."

Some studies have shown that opening the blocked artery within 120 minutes is associated with good clinical outcomes, for example. In addition, door-to-balloon time is a flawed metric, Dr. Henry said. A more clinically relevant indicator would be time to reperfusion, or
'"/>




Page: 1 2

Related medicine news :

1. Debate Rages over firing of HIV infected health care workers
2. Debate On Marriage
3. New Mexico Debates Over Forcing Mentally Ill People To Seek Treatment
4. Debate in US: Who Should Decide for Disabled People?
5. Skinny Debate Upsets Actress Knightley
6. Skinny Debate Upsets Actress Knightley
7. Republican Presidential Candidates Discuss Abortion, Stem Cells as Part of First Debate
8. Scientists Saying Against Trees Sparks Debate
9. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
10. Canada Focuses Its Attention on Kids
11. Study Focuses on Womens Health After Breast Cancer
Post Your Comments:
(Date:12/2/2008)...EAK to collect and disseminate pharmacy experience...ue, Wash. (PRWEB) December 2, 2008 -- Pharmacy On... initiative to focus public and industry attention...ck-off of SPEAK will occur during the American Soc...ear Clinical Meeting, to be held December 7-11 in ...
(Date:12/2/2008)... this year,s ASHP midyear meeting, FFF Enterprises...r of critical-care biopharmaceuticals and vaccines...chain integrity and demonstrate how the company ha.... (Booth #1439) , (Vocus)...eeting, FFF Enterprises, the nation,s largest and ...
(Date:12/2/2008)... the International Day of Disabled Persons is reco...story of a young boy born with backwards pointing ...y, a floating hospital docked in Liberia, Benedict...with the other children his age. High resolution...hipsnewsroom.org , Garde...
(Date:12/2/2008)...ar Unafraid: Learning to Trust No Matter What by J...2008 Awards.,In 1977, strange symptoms assaulted ... with multiple sclerosis. Jo had backpacked up 14,...ty miles an hour. , Battl...raid: Learning to Trust No Matter What by Jo Franz...
Breaking Medicine News(10 mins):Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 3Health News:Mercy Ships Recognizes International Day of Disabled Persons 2Health News:Mercy Ships Recognizes International Day of Disabled Persons 3Health News:Nothing Has Stopped This Woman--MS, Divorce, Abuse, Trauma--How to Live Adventurously and Fearlessly No Matter What Happens 2Health News:Nothing Has Stopped This Woman--MS, Divorce, Abuse, Trauma--How to Live Adventurously and Fearlessly No Matter What Happens 3
...ttent treatment with sulfadoxine-pyrimethamine, a ... in treating malaria in Mozambican children //by R...edro Alonso, coordinator of the Centre of Internat... findings of their study are to be published in th...
...e backdrop of questions being raised about its aut...of making the All India Institute of Medical Scien...ies". "We hope we can come out with some recommen...e as possible from authorities," M S Valiathan, wh...
... live alone are twice as likely to have serious he...s a new study//. According to a study published in... Danish researchers surveyed around 1,38,000 adult... in one area of Denmark and found that certain hea...
...n reported that doctors from the Michigan State Un...treatment plan, which allows a more effective// me...r people suffering from symptoms and conditions th...Smith, a physician and professor in MSU’s Departme...
Other Medicine News:Health News:Intermittent Treatment Found Effective In Malaria 2Health News:Intermittent Treatment Found Effective In Malaria 3Health News:Intermittent Treatment Found Effective In Malaria 4Health News:Intermittent Treatment Found Effective In Malaria 5Health News:Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms 2
(Date:11/25/2008)...Nov. 25 Proteolix, Inc., a,leader...utics that target,protein degradation pathways in...that data from two ongoing Phase 2 clinical trials...nted at the upcoming 50th Annual Meeting of the,A...is the first in a new class,of specific proteasom...
(Date:11/25/2008)...ical Trial to Assess Survival of Patients Receivin...ectable Hepatocellular Carcinoma , , BELLEV...Oncology, Inc. (LSO) today announced the completio... of Light Infusion Therapy(TM) (Litx(TM)) as a tre...HCC), also known as hepatoma or primary liver canc...
(Date:11/24/2008)...Newswire/ -- Domino,s Pizza (NYSE: DPZ ), the,r...ng up to raise dough for,the kids of St. Jude Chi...,Thanks and Giving campaign. Domino,s customers wi...nt of purchase to benefit the children of St. Jude...one or when ordering online at, www.dominos.com ....
(Date:11/24/2008)...ion leadership and long-term commitment to hepatit...PRNewswire-FirstCall/ -- Schering-Plough Corporati... on boceprevir, its lead investigational oral hepa...development. The company believes boceprevir has ...lass protease inhibitor for treating chronic hepat...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 24151 1Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 24151 2U S Health Care Still Ill Survey Finds 24149 1U S Health Care Still Ill Survey Finds 24149 2U S Health Care Still Ill Survey Finds 24149 3Aethons Train Themed Delivery Robot Available To Childrens Hospitals Nationwide 24147 1Aethons Train Themed Delivery Robot Available To Childrens Hospitals Nationwide 24147 2WeissComm Partners Ranks Among Top 5 Best U S Midsize PR Agencies to Work For 24145 1WeissComm Partners Ranks Among Top 5 Best U S Midsize PR Agencies to Work For 24145 2
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTN/1Q-CAB chairs are
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTN/1Q-CAB chairs are
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTN/1Q-CAB chairs are
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTN/1Q-CAB chairs are
Medicine Products: